Novo Nordisk’s Wegovy cuts heart risk by 57% versus rival Lilly weight-loss drug in study Reuters Weight loss drugs can halve heart patients’ risk of early death, study finds The Guardian Novo Nordisk’s Wegovy® cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular disease PR Newswire Weight loss jabs could …
Read More »Tag Archives: Nordisk039s
Novo Nordisk's Wegovy gets accelerated US approval for liver disease MASH – Reuters
Novo Nordisk’s Wegovy gets accelerated US approval for liver disease MASH Reuters Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis PR Newswire Novo Nordisk’s obesity drug Wegovy cleared to treat MASH statnews.com Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH Yahoo Finance Novo Nordisk’s Wegovy Gets US Approval for …
Read More »